CD8A and neoplasm: The conversion into the M2 phenotype also inhibits the cytotoxicity of tumor antigen-specific CD8+ T-cells (Baghdadi et al., 2016; Giulianelli et al., 2019; Sung et al., 2019; Blondy et al., 2020).